Targeting CD38 in Patients With Relapsed/Refractory Multiple Myeloma
EP. 1: The Impact of CD38-Targeted Therapy in Multiple Myeloma
January 10th 2020
EP. 2: Available CD38 Antibodies for Multiple Myeloma
January 10th 2020
EP. 3: ICARIA-MM Phase III Trial Overview
January 10th 2020
EP. 4: Future Direction of CD38 Antibodies in Multiple Myeloma
January 10th 2020
